2. Gene
  3. KDR - kinase insert domain receptor Gene

KDR - kinase insert domain receptor Gene

  • 基因
  • 蛋白
  • 相关产品
  • 直系同源

中文名称：激酶插入域受体

种属: Felis catus

基因 ID: 101090260 | 基因类型: protein coding

关于 KDR

KDR 基因产物(1)

mRNA Protein Name
XM_011281879.4 XP_011280181.3 vascular endothelial growth factor receptor 2
蛋白主名 其他名称

vascular endothelial growth factor receptor 2

kinase insert domain receptor (a type III receptor tyrosine kinase)

相关产品

Approval
生物活性分子 (9)
目录号 产品名 作用方式
纯度 是否罕见病
HY-16749 Pexidartinib 99.64% 是
HY-10260 Vandetanib 99.95% 是
HY-112306 Ripretinib 99.33% 是
HY-16749A Pexidartinib hydrochloride 99.89% 是
HY-10330A Toceranib phosphate Inhibitor 98.54% 否
HY-10330 Toceranib Inhibitor 96.86% 否
HY-14914 Azilsartan 99.51% 否
HY-10260B Vandetanib hydrochloride / 否
HY-10260A Vandetanib trifluoroacetate / 否
Clinical Phase
生物活性分子 (13)
目录号 产品名 作用方式
纯度 Phase
HY-50751 Linifanib 99.28% Phase 3
HY-10205 Cediranib 99.58% Phase 3
HY-12018 Vatalanib dihydrochloride 99.91% Phase 3
HY-13314 Tesevatinib Inhibitor 99.21% Phase 3
HY-13049 Cediranib maleate 99.84% Phase 3
HY-50751G Linifanib (GMP) Inhibitor / Phase 3
HY-10203 Vatalanib Inhibitor / Phase 3
HY-10374 Semaxinib Inhibitor 99.96% Phase 2
HY-10338 Foretinib Inhibitor 99.77% Phase 2
HY-13024 Rebastinib 99.91% Phase 2
HY-10987A ENMD-2076 99.12% Phase 2
HY-10987 ENMD-2076 Tartrate 99.42% Phase 2
HY-10204 OSI-930 98.57% Phase 1
Pre-clinical Phase
生物活性分子 (27)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-12299 WH-4-023 Inhibitor 99.75% 否
HY-151361 AMPK-IN-3 Inhibitor 98.51% 否
HY-13838 PLX647 Inhibitor 99.79% 否
HY-13561 AZM475271 Inhibitor 99.85% 否
HY-W062835 CGP77675 Inhibitor 99.00% 否
HY-132135 (1E)-CFI-400437 dihydrochloride Inhibitor 98.89% 否
HY-100315 Tyrosine kinase-IN-1 Inhibitor 99.34% 否
HY-15769 WHI-P180 Inhibitor 99.62% 否
HY-133551 WF-47-JS03 Inhibitor 99.63% 否
HY-13785 ZM 306416 Inhibitor 99.80% 否
HY-10517A (Z)-Orantinib Inhibitor 99.02% 否
HY-101219 VEGFR-IN-1 Inhibitor 98.42% 否
HY-119757 Tyrphostin AG1433 Inhibitor 99.08% 否
HY-18302 c-Kit-IN-5-1 Inhibitor 98.16% 否
HY-10260S Vandetanib-d6 / 否
HY-10260S1 Vandetanib-d4 / 否
HY-10330S Toceranib-d8 Inhibitor / 否
HY-110272 Vatalanib succinate Inhibitor / 否
HY-120214 TAS05567 Inhibitor / 否
HY-125741 GW768505A free base Inhibitor 98.66% 否
HY-13838A PLX647 dihydrochloride Inhibitor / 否
HY-14979A ML786 dihydrochloride Inhibitor / 否
HY-15814 HG-7-85-01 / 否
HY-18318 Takeda-6D Inhibitor / 否
HY-W062835A CGP77675 hydrate Inhibitor / 否
HY-15769A WHI-P180 hydrochloride Inhibitor / 否
HY-101628 VEGFR-2-IN-9 Inhibitor / 否
抗体抑制剂 (2)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-P99768 Olinvacimab Inhibitor 95.00% 否
HY-P99830 Conbercept / 否

直系同源

种属 基因名 来源 基因 ID
Homo sapiens KDR NCBI NCBI:3791
Rattus norvegicus KDR NCBI NCBI:25589
Macaca mulatta KDR NCBI NCBI:698293